Real-World Experience with Novel VMAT2 Inhibitors

被引：0
作者：
Niemann, Nicki [1 ]
Jankovic, Joseph [1 ]
机构：
[1] Baylor Coll Med, Parkinsons Dis Ctr & Movement Disorders Clin, Dept Neurol, Houston, TX 77030 USA
来源：
NEUROTHERAPEUTICS | 2018年 / 15卷 / 04期
关键词：
TETRABENAZINE;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
59
引用
收藏
页码：1190 / 1191
页数：2
相关论文
共 6 条
  • [1] Treatment options for chorea
    Bashir, H.
    Jankovic, J.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (01) : 51 - 63
  • [2] Long-term effects of tetrabenazine in hyperkinetic movement disorders
    Jankovic, J
    Beach, J
    [J]. NEUROLOGY, 1997, 48 (02) : 358 - 362
  • [3] Short-term effects of tetrabenazine on chorea associated with Huntington's disease
    Kenney, Christopher
    Hunter, Christine
    Davidson, Anthony
    Jankovic, Joseph
    [J]. MOVEMENT DISORDERS, 2007, 22 (01) : 10 - 13
  • [4] Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders
    Kenney, Christopher
    Hunter, Christine
    Jankovic, Joseph
    [J]. MOVEMENT DISORDERS, 2007, 22 (02) : 193 - 197
  • [5] Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors
    Niemann, Nicki
    Jankovic, Joseph
    [J]. DRUGS, 2018, 78 (05) : 525 - 541
  • [6] Palao A, 2011, MOV DISORD S2, pS259
1